A new pill, enlicitide, reduced LDL (“bad”) cholesterol by about 60% in a large clinical trial, matching the power of ...

AI is rewriting drug discovery. Recursion Pharmaceuticals and Tempus AI might be the platforms that turn early investors into millionaires.

Semaglutide’s patent expiry could transform weight loss drug access, with cheaper generics and up to 50 brands launching in India. Prices may drop significantly, improving affordability and ...

The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in ...

However, a decision taken by the company earlier in 2024 underlined how researchers in sectors like drug discovery see the importance of the tool by triggering the creation of multiple workalikes ...

Gilead HPI licensing adds $35M now + $330M milestones; Phase 2 starts by 2026; strong cash runway. Click for this ASMB update ...

Welcome to Brii Bio's 2025 Full Year Financial Results and Corporate Update Conference Call. Our annual result announcements can be found on the Investor Relations section of our company website.

This week on "The Readout LOUD," a conversation with biotech "godfather" Stelios Papadapolous live from #STATBreakthrough.

The Motley Fool reports that biotech stocks surged in 2025, driven by FDA approvals and a doubling of longevity investment to $8.49 billion.

While parts of the US government have pledged for years to reduce animal testing, experts say the FDA especially has been slow to respond, implement and permit the use of ...

For STEM students considering career paths, the PA, NJ, & DE region is recognized as one of the leading biotechnology & ...

The rapid development of artificial intelligence (AI) technology has become a cornerstone of multidisciplinary research worldwide, establishing a new paradigm of "AI for Science." AI is progressively ...